DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
Lin NU. et al
Tucatinib vs placebo added to trastuzumab and capecitabine for patients with previously treated HER2 + metastatic breast cancer with brain metastases (HER2CLIMB)..
ASCO 2020 Abstract 1005
We do not assume any responsibility for the contents of the web pages of other providers.